# First Line Chemotherapy for Advanced Cancer

> **NCT01980810** · PHASE2 · TERMINATED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 36 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** albumin-bounded paclitaxel
- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT01980810
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2015-02
- **Final completion:** 2016-02
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** recruit too slowly
- **Last updated:** 2016-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980810, "First Line Chemotherapy for Advanced Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01980810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*